We provide medications for obesity and/or binge eating when combined with consistent therapy. Current research indicates the GIP/GLP1a medications may also significantly reduce opioid or alcohol overuse.
Mounjaro/Zepbound (tirzepatide) GIP for weight management
Wegovy (semaglutide) GLP1a for weight management
Vyvanse (lisdexamfetamine) for binge eating disorder